B BIONICS INSTITUTE
LIVE

Serial Number

79342541

Owner

The Bionics Institute of Australia

Attorney

Anne Wang

Filing Date

Apr 1, 2022

Add to watchlist:

No watchlists yet
View on USPTO

B BIONICS INSTITUTE Trademark

Serial Number: 79342541 • Registration: 7435181

B BIONICS INSTITUTE is a trademark filed by The Bionics Institute of Australia on April 1, 2022. The trademark is classified under Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

The Bionics Institute of Australia (5 trademarks)

384-388 Albert Street

Entity Type: 03

Trademark Details

Filing Date

April 1, 2022

Registration Date

July 9, 2024

Published for Opposition

April 23, 2024

Goods & Services

Medical apparatus and instruments, namely, medical apparatus and instruments for use in neuromodulation and medical apparatus and instruments for the diagnosis, monitoring, management and treatment of hearing disorders; electronic medical apparatus, namely, electronic medical apparatus for use in neuromodulation and the electronic medical apparatus for the diagnosis, monitoring, management and treatment of hearing disorders; medical diagnostic devices and instruments, namely, medical diagnostic devices and instruments for use in neuromodulation and medical diagnostic devices and instruments for the diagnosis, monitoring, management and treatment of hearing disorders; medical devices and instruments for monitoring and treating health and medical conditions, namely, medical devices and instruments for monitoring and treating health and medical conditions by way of neuromodulation and medical devices and instruments for monitoring and treating health and medical conditions, namely, hearing disorders, epilepsy and parkinson's disease; medical implants, namely, medical implants for use in neuromodulation and medical implants for the diagnosis, monitoring, management and treatment of hearing disorders, epilepsy and parkinson's disease, all being made from artificial materials; wearable medical devices, namely, wearable medical devices for use in neuromodulation and wearable medical devices for the diagnosis, monitoring, management and treatment of hearing disorders, epilepsy and parkinson's disease; hearing aids; apparatus for use in alleviating hearing disorders, namely, hearing aids and cochlea implants made of artificial materials; apparatus for use in treating hearing disorders, namely, hearing aids and cochlea implants made of artificial materials; apparatus for use in the diagnosis, monitoring and treatment of neurological conditions and central nervous system disorders, including parkinson's disease and epilepsy; sensors being measurement apparatus for medical use, namely, biofeedback sensors

Printed matter, namely, books, journals, magazines and brochures in the field of medical research and medical practice; printed publications, namely, books, journals, magazines and brochures in the field of medical research and medical practice; printed journals in the field of medical research and medical practice; printed newsletters and printed magazines in the field of medical research and medical practice; all the aforementioned being in relation to medical research and medical matters

Medical research; medical research in the field of neurological conditions and central nervous system disorders; medical research in the field of parkinson's disease; medical research in the field of epilepsy; medical research in the field of hearing disorders; technological research and design in the field of medical devices, apparatus and instruments; technological research and design of computer hardware, firmware and software for use in the medical field; software as a service (saas) for use in the medical field featuring software for diagnosing, monitoring, managing, and treating health and medical conditions; platforms as a service (paas) for use in the medical field featuring software platforms for diagnosing, monitoring, managing, and treating health and medical conditions; installation, maintenance and repair of computer firmware and computer software for use in the medical field, namely, for use with medical devices for the diagnosis, monitoring, management and treatment of health and medical conditions

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 4, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 13, 2024 FICS
FINAL DISPOSITION PROCESSED
Dec 13, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 9, 2024 FICR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 12, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 12, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 12, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 12, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 12, 2024 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 9, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 9, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 25, 2024 NPUB
NOTIFICATION PROCESSED BY IB
Apr 23, 2024 GPNX
PUBLISHED FOR OPPOSITION
Apr 23, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 3, 2024 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 3, 2024 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 3, 2024 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 19, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2024 CRFA
ASSIGNED TO LIE
Feb 27, 2024 ALIE
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 11, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 22, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 22, 2023 OPNR
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 5, 2023 TROA
NOTICE OF REVIVAL - E-MAILED
Oct 5, 2023 NREV
PETITION TO REVIVE-GRANTED
Oct 5, 2023 PETG
TEAS PETITION TO REVIVE RECEIVED
Oct 5, 2023 PROA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Oct 3, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Oct 3, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 3, 2023 ABN2
REFUSAL PROCESSED BY IB
Apr 13, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 17, 2023 RFCS
REFUSAL PROCESSED BY MPU
Mar 17, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 25, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jan 24, 2023 CNRT
ASSIGNED TO EXAMINER
Jan 19, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 28, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 22, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 21, 2022 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 16, 2022 REPR